Samuel Gavard Molliard

Samuel Gavard Molliard

Anteis SA, a wholly owned subsidiary of Merz Pharmaceuticals GmbH, Chemin des Aulx 18, 1228 Plan-les-Ouates, Switzerland.

Biography

Dr. Samuel Gavard Molliard is currently working at Merz Pharmaceuticals GmbH. Author’s significant publications include “Influence of the Macro- and/or Microstructure of Cross-Linked Hyaluronic Acid Hydrogels on the Release of Two Model Drugs”. Author current research interests include Hyaluronic Acid, Matrix structure, Lidocaine, Polysaccharide.

Research Interest

Hyaluronic aci, Drug resistance

Journal of Glycobiology
Open Access